Etoricoxib

Definition: Etoricoxib, sold under brand names including Arcoxia, Exinef and Nucoxia is a selective COX-2 inhibitor developed and commercialized by Merck. It is approved in 63 countries worldwide as of 2007, except the United States where the Food and Drug Administration sent a Non Approvable Letter to Merck and required them to provide additional data. source: Wikipedia

ID

409134009

ID date

1 Aug 2005

Previous ID

3531911000001106

Name

Etoricoxib